Journey Medical Corporation to Announce Second Quarter 2023 Financial Results the Week of August 7, 2023

Rhea-AI Summary

Journey Medical Corporation will release its second quarter 2023 financial results during the week of August 7, 2023. The company will also host a conference call to discuss the results and provide a corporate update.

Positive

• Investors can expect to gain insights into the company's financial performance for the second quarter of 2023, which could positively impact stock price if the results exceed expectations.

Negative

• There are no concrete negative business takes available at the moment.

Company to host conference call to discuss financial results and provide a corporate update the week of August 7, 2023

SCOTTSDALE, Ariz., July 19, 2023 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that the Company will release its second quarter 2023 financial results during the week of August 7, 2023. Journey Medical management will conduct a conference call and audio webcast. Details will be provided at a later date.

About Journey Medical Corporation
Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”) is a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions through its efficient sales and marketing model. The company currently markets eight branded and three generic products that help treat and heal common skin conditions. The Journey Medical team comprises industry experts with extensive experience in developing and commercializing some of dermatology’s most successful prescription brands. Journey Medical is located in Scottsdale, Arizona and was founded by Fortress Biotech, Inc. (Nasdaq: FBIO). Journey Medical’s common stock is registered under the Securities Exchange Act of 1934, as amended, and it files periodic reports with the U.S. Securities and Exchange Commission (“SEC”). For additional information about Journey Medical, visit www.journeymedicalcorp.com.

Company Contact:
Jaclyn Jaffe
Journey Medical Corporation
(781) 652-4500
ir@jmcderm.com

Media Relations Contact:
Tony Plohoros
6 Degrees
(908) 591-2839
tplohoros@6degreespr.com  

FAQ

When will Journey Medical Corporation release its second quarter 2023 financial results?

The company will release its second quarter 2023 financial results during the week of August 7, 2023.

Will there be a conference call to discuss the financial results?

Yes, Journey Medical Corporation will host a conference call to discuss the financial results and provide a corporate update.

What can investors expect from the conference call?

Investors can expect to gain insights into the company's financial performance for the second quarter of 2023, which could positively impact stock price if the results exceed expectations.